相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Psychedelics and Psychedelic-Assisted Psychotherapy
Collin M. Reiff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
Lea J. Mertens et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials
Ana Sofia Vargas et al.
BIOMEDICINES (2020)
The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
Yoav Domany et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Denver votes to decriminalise psilocybin mushrooms
Paul Webster
LANCET (2019)
Data Extraction from Graphs Using Adobe Photoshop: Applications for Meta-Analyses
Sevda Gheibi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2019)
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
Somaye Arabzadeh et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Serotonin and brain function: a tale of two receptors
R. L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Robin L. Carhart-Harris et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
Randall T. Brown et al.
CLINICAL PHARMACOKINETICS (2017)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis
Toshi A. Furukawa et al.
BMJ OPEN (2016)
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice
Olga Zhuk et al.
TOXINS (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression
E. Vassos et al.
MOLECULAR PSYCHIATRY (2014)
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
David Baumeister et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
Power failure: why small sample size undermines the reliability of neuroscience
Katherine S. Button et al.
NATURE REVIEWS NEUROSCIENCE (2013)
A fatal case of magic mushroom' ingestion in a heart transplant recipient
T. H. Lim et al.
INTERNAL MEDICINE JOURNAL (2012)
Development of Lifetime Comorbidity in the World Health Organization World Mental Health Surveys
Ronald C. Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Harm potential of magic mushroom use: A review
Jan van Amsterdam et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Hallucinogens as Medicine
Roland R. Griffiths et al.
SCIENTIFIC AMERICAN (2010)
Cachexia: A new definition
William J. Evans et al.
CLINICAL NUTRITION (2008)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone
Rachel Manber et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2008)
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Saba Moussavi et al.
LANCET (2007)
Acute time to response in the Treatment for Adolescents with Depression Study (TADS)
Christopher Kratochvil et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2006)
Attenuation of the neural response to sad faces in major depression by antidepressant treatment - A prospective, event-related functional magnetic resonance imaging study
CHY Fu et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
分享论文
